JP2019218385A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019218385A5 JP2019218385A5 JP2019156299A JP2019156299A JP2019218385A5 JP 2019218385 A5 JP2019218385 A5 JP 2019218385A5 JP 2019156299 A JP2019156299 A JP 2019156299A JP 2019156299 A JP2019156299 A JP 2019156299A JP 2019218385 A5 JP2019218385 A5 JP 2019218385A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- pharmaceutical composition
- composition according
- calcium
- magnesium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021087768A JP2021130689A (ja) | 2013-12-12 | 2021-05-25 | フマル酸ジメチルを含む医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13382504 | 2013-12-12 | ||
| EP13382504.2 | 2013-12-12 | ||
| JP2016538622A JP6581088B2 (ja) | 2013-12-12 | 2014-12-05 | フマル酸ジメチルを含む医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538622A Division JP6581088B2 (ja) | 2013-12-12 | 2014-12-05 | フマル酸ジメチルを含む医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087768A Division JP2021130689A (ja) | 2013-12-12 | 2021-05-25 | フマル酸ジメチルを含む医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019218385A JP2019218385A (ja) | 2019-12-26 |
| JP2019218385A5 true JP2019218385A5 (https=) | 2020-07-16 |
| JP6945603B2 JP6945603B2 (ja) | 2021-10-06 |
Family
ID=49917530
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538622A Active JP6581088B2 (ja) | 2013-12-12 | 2014-12-05 | フマル酸ジメチルを含む医薬組成物 |
| JP2019156299A Active JP6945603B2 (ja) | 2013-12-12 | 2019-08-29 | フマル酸ジメチルを含む医薬組成物 |
| JP2021087768A Pending JP2021130689A (ja) | 2013-12-12 | 2021-05-25 | フマル酸ジメチルを含む医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538622A Active JP6581088B2 (ja) | 2013-12-12 | 2014-12-05 | フマル酸ジメチルを含む医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087768A Pending JP2021130689A (ja) | 2013-12-12 | 2021-05-25 | フマル酸ジメチルを含む医薬組成物 |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US20160310457A1 (https=) |
| EP (2) | EP3656379A1 (https=) |
| JP (3) | JP6581088B2 (https=) |
| KR (2) | KR102335289B1 (https=) |
| CN (2) | CN114159421B (https=) |
| AR (1) | AR098746A1 (https=) |
| AU (2) | AU2014363792B2 (https=) |
| BR (1) | BR112016012179B1 (https=) |
| CA (2) | CA2932054C (https=) |
| CL (1) | CL2016001415A1 (https=) |
| CY (1) | CY1124336T1 (https=) |
| DK (1) | DK3079666T3 (https=) |
| EA (1) | EA201600457A1 (https=) |
| ES (1) | ES2860551T3 (https=) |
| HR (1) | HRP20210468T1 (https=) |
| HU (1) | HUE054408T2 (https=) |
| IL (2) | IL287109B (https=) |
| LT (1) | LT3079666T (https=) |
| MX (2) | MX375144B (https=) |
| MY (1) | MY179355A (https=) |
| NZ (2) | NZ720287A (https=) |
| PH (2) | PH12016501043B1 (https=) |
| PL (1) | PL3079666T3 (https=) |
| PT (1) | PT3079666T (https=) |
| RS (1) | RS61658B1 (https=) |
| SG (3) | SG10201802815UA (https=) |
| SI (1) | SI3079666T1 (https=) |
| SM (1) | SMT202100205T1 (https=) |
| TW (2) | TWI704915B (https=) |
| UA (2) | UA120428C2 (https=) |
| WO (1) | WO2015086467A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10098863B2 (en) | 2014-02-28 | 2018-10-16 | Banner Life Sciences Llc | Fumarate esters |
| US9636318B2 (en) | 2015-08-31 | 2017-05-02 | Banner Life Sciences Llc | Fumarate ester dosage forms |
| US9326947B1 (en) | 2014-02-28 | 2016-05-03 | Banner Life Sciences Llc | Controlled release fumarate esters |
| ES2713157T3 (es) | 2014-02-28 | 2019-05-20 | Banner Life Sciences Llc | Cápsulas blandas entéricas de liberación controlada de ésteres de fumarato |
| WO2016194004A1 (en) * | 2015-06-01 | 2016-12-08 | Sun Pharmaceutical Industries Ltd. | Pharmaceutical compositions of dimethyl fumarate |
| CA2990230A1 (en) | 2015-06-19 | 2016-12-22 | University Of Southern California | Compositions and methods for modified nutrient delivery |
| US10744070B2 (en) | 2015-06-19 | 2020-08-18 | University Of Southern California | Enteral fast access tract platform system |
| WO2017040272A1 (en) * | 2015-08-31 | 2017-03-09 | Banner Life Sciences Llc | Fumarate ester dosage forms |
| EP3397247B1 (en) * | 2015-12-31 | 2023-06-07 | Zaklady Farmaceutyczne Polpharma SA | Process for preparation of an enteric coated granulate comprising dimethyl fumarate |
| PL3407873T3 (pl) * | 2016-01-28 | 2025-01-13 | Zakłady Farmaceutyczne POLPHARMA S.A. | Sposób otrzymywania granulatu zawierającego fumaran dimetylu |
| JP2019510743A (ja) * | 2016-02-12 | 2019-04-18 | ウニヴェルズィテート チューリッヒ | 痛風、ざ瘡及び糖尿病の予防又は治療のためのジメチルフマレート（ｄｍｆ） |
| WO2017145036A1 (en) * | 2016-02-25 | 2017-08-31 | Aurobindo Pharma Ltd | Pharmaceutical compositions comprising dimethyl fumarate |
| KR20200018458A (ko) | 2017-06-23 | 2020-02-19 | 알미랄, 에스.에이. | 디메틸 푸마레이트를 포함하는 약학 조성물 |
| JP7000148B2 (ja) * | 2017-12-27 | 2022-01-19 | 日本化薬株式会社 | ダサチニブを有効成分とする医薬組成物 |
| WO2020053218A1 (en) | 2018-09-13 | 2020-03-19 | Almirall, S.A. | Treatment of psoriasis |
| WO2020053219A1 (en) | 2018-09-13 | 2020-03-19 | Almirall, S.A. | Treatment of psoriasis |
| AU2020283238B2 (en) * | 2019-05-31 | 2022-07-07 | Curacle Co., Ltd. | Enteric tablet containing dimethyl fumarate |
| JP6744518B1 (ja) * | 2019-11-07 | 2020-08-19 | 旭化成株式会社 | セルロース組成物及び錠剤 |
| US11903918B2 (en) | 2020-01-10 | 2024-02-20 | Banner Life Sciences Llc | Fumarate ester dosage forms with enhanced gastrointestinal tolerability |
| US12138351B2 (en) * | 2020-04-14 | 2024-11-12 | Janssen Biotech, Inc. | Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or pharmaceutically acceptable salt, hydrate, or solvate thereof |
| WO2022203432A1 (ko) * | 2021-03-25 | 2022-09-29 | 주식회사 큐라클 | 특정 약동학적 매개변수를 나타내는 디메틸푸마레이트를 유효성분으로 함유한 약학적 조성물 |
| EP4313023A1 (en) * | 2021-04-02 | 2024-02-07 | Biogen MA Inc. | Combination treatment methods of multiple sclerosis |
| WO2024232931A1 (en) * | 2023-05-11 | 2024-11-14 | Yon Doo Ough | Apparatus and method for contact free delivery and administration of magnesium as a drug |
| WO2025235457A1 (en) | 2024-05-09 | 2025-11-13 | Alsteni Medical, Inc. | Intraoral gastrointestinal access device and related methods |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4959389A (en) | 1987-10-19 | 1990-09-25 | Speiser Peter P | Pharmaceutical preparation for the treatment of psoriatic arthritis |
| DE19848260C2 (de) | 1998-10-20 | 2002-01-17 | Fumapharm Ag Muri | Fumarsäure-Mikrotabletten |
| DE19853487A1 (de) * | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
| DE10101307A1 (de) * | 2001-01-12 | 2002-08-01 | Fumapharm Ag Muri | Fumarsäurederivate als NF-kappaB-Inhibitor |
| PL2316430T3 (pl) * | 2004-10-08 | 2012-11-30 | Forward Pharma As | Kompozycje farmaceutyczne o kontrolowanym uwalnianiu, zawierające ester kwasu fumarowego |
| CN101056624A (zh) * | 2004-10-08 | 2007-10-17 | Adi技术制药股份公司 | 包含富马酸酯的控释药物组合物 |
| EP1877059B8 (en) * | 2005-04-28 | 2010-05-19 | Wyeth a Corporation of the State of Delaware | Micronized tanaproget and compostions containing same |
| CN101304732A (zh) * | 2005-10-07 | 2008-11-12 | Adi技术制药股份公司 | 包含富马酸酯的控释药物组合物 |
| WO2007042034A1 (en) * | 2005-10-07 | 2007-04-19 | Aditech Pharma Ab | Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| EP1940382A2 (en) * | 2005-10-07 | 2008-07-09 | Aditech Pharma AB | Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders |
| WO2009118764A1 (en) * | 2008-03-28 | 2009-10-01 | Panacea Biotec Limited | Pharmaceutical composition comprising diclofenac and paracetamol |
| EP2379062A1 (en) | 2009-01-09 | 2011-10-26 | Forward Pharma A/S | Pharmaceutical composition comprising one or more fumaric acid esters |
| CN102369001A (zh) | 2009-01-09 | 2012-03-07 | 前进制药公司 | 包含溶蚀骨架中的一种或多种富马酸酯的药物制剂 |
| JP2012525385A (ja) * | 2009-04-29 | 2012-10-22 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 神経変性および神経炎症の治療 |
| US20120308562A1 (en) * | 2011-06-03 | 2012-12-06 | Derynck Mika K | Methods of treating mesothelioma with a pi3k inhibitor compound |
| WO2013076216A1 (en) | 2011-11-24 | 2013-05-30 | Synthon Bv | Controlled release particles comprising dimethyl fumarate |
| CN114146081A (zh) * | 2012-02-07 | 2022-03-08 | 比奥根玛公司 | 含有富马酸二甲酯的药物组合物 |
-
2014
- 2014-12-05 SM SM20210205T patent/SMT202100205T1/it unknown
- 2014-12-05 NZ NZ720287A patent/NZ720287A/en unknown
- 2014-12-05 UA UAA201607363A patent/UA120428C2/uk unknown
- 2014-12-05 EP EP19217154.4A patent/EP3656379A1/en active Pending
- 2014-12-05 PL PL14809821T patent/PL3079666T3/pl unknown
- 2014-12-05 CN CN202111543717.7A patent/CN114159421B/zh active Active
- 2014-12-05 PT PT148098213T patent/PT3079666T/pt unknown
- 2014-12-05 CN CN201480066692.8A patent/CN105813634A/zh active Pending
- 2014-12-05 EA EA201600457A patent/EA201600457A1/ru unknown
- 2014-12-05 HR HRP20210468TT patent/HRP20210468T1/hr unknown
- 2014-12-05 ES ES14809821T patent/ES2860551T3/es active Active
- 2014-12-05 MX MX2016007105A patent/MX375144B/es active IP Right Grant
- 2014-12-05 SI SI201431799T patent/SI3079666T1/sl unknown
- 2014-12-05 SG SG10201802815UA patent/SG10201802815UA/en unknown
- 2014-12-05 JP JP2016538622A patent/JP6581088B2/ja active Active
- 2014-12-05 CA CA2932054A patent/CA2932054C/en active Active
- 2014-12-05 BR BR112016012179-1A patent/BR112016012179B1/pt active IP Right Grant
- 2014-12-05 EP EP14809821.3A patent/EP3079666B1/en active Active
- 2014-12-05 KR KR1020167015498A patent/KR102335289B1/ko active Active
- 2014-12-05 SG SG10201913080VA patent/SG10201913080VA/en unknown
- 2014-12-05 RS RS20210404A patent/RS61658B1/sr unknown
- 2014-12-05 US US15/103,465 patent/US20160310457A1/en not_active Abandoned
- 2014-12-05 LT LTEP14809821.3T patent/LT3079666T/lt unknown
- 2014-12-05 AU AU2014363792A patent/AU2014363792B2/en active Active
- 2014-12-05 HU HUE14809821A patent/HUE054408T2/hu unknown
- 2014-12-05 CA CA3135273A patent/CA3135273A1/en not_active Abandoned
- 2014-12-05 SG SG10201913076PA patent/SG10201913076PA/en unknown
- 2014-12-05 KR KR1020217038861A patent/KR102353201B1/ko active Active
- 2014-12-05 DK DK14809821.3T patent/DK3079666T3/da active
- 2014-12-05 NZ NZ759411A patent/NZ759411A/en unknown
- 2014-12-05 IL IL287109A patent/IL287109B/en unknown
- 2014-12-05 WO PCT/EP2014/076767 patent/WO2015086467A1/en not_active Ceased
- 2014-12-05 UA UAA201906965A patent/UA123880C2/uk unknown
- 2014-12-05 MY MYPI2016702094A patent/MY179355A/en unknown
- 2014-12-10 TW TW108144916A patent/TWI704915B/zh active
- 2014-12-10 TW TW103143092A patent/TWI687218B/zh active
- 2014-12-12 AR ARP140104646A patent/AR098746A1/es unknown
-
2016
- 2016-05-17 IL IL245685A patent/IL245685B/en unknown
- 2016-06-01 MX MX2020009745A patent/MX2020009745A/es unknown
- 2016-06-02 PH PH12016501043A patent/PH12016501043B1/en unknown
- 2016-06-09 CL CL2016001415A patent/CL2016001415A1/es unknown
-
2019
- 2019-08-29 JP JP2019156299A patent/JP6945603B2/ja active Active
- 2019-11-19 AU AU2019268075A patent/AU2019268075B2/en active Active
- 2019-11-21 PH PH12019502610A patent/PH12019502610A1/en unknown
-
2021
- 2021-04-27 CY CY20211100359T patent/CY1124336T1/el unknown
- 2021-05-11 US US17/316,861 patent/US20210330628A1/en not_active Abandoned
- 2021-05-25 JP JP2021087768A patent/JP2021130689A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019218385A5 (https=) | ||
| JP2016540003A5 (https=) | ||
| HRP20210468T1 (hr) | Farmaceutski pripravci koji sadrže dimetil fumarat | |
| US7790921B2 (en) | Methods for the preparation, formulation and use of lithium valproate | |
| HRP20240355T1 (hr) | 8-cijano-5-piperidino-kinolini kao tlr7/8 antagonisti i njihova upotreba u liječenju imunoloških poremećaja | |
| JP5837726B1 (ja) | アルキルエーテル誘導体またはその塩を含有する神経損傷後のリハビリテーション効果促進剤 | |
| CN110944638A (zh) | 尼拉帕尼组合物 | |
| KR102759845B1 (ko) | 2-｛4-[n-(5,6-디페닐피라진-2-일)-n-이소프로필아미노]부틸옥시｝-n-(메틸술포닐)아세트아미드를 함유하는 의약 조성물 | |
| ME01629B (me) | Upotreba 3,11 b-cis-dihidrotetrabenazina za tretman simptoma huntington-ove bolesti | |
| FI3993777T3 (fi) | Kompressoidut masitentaanikoostumukset, menetelmät ja niiden käytöt | |
| US20180147148A1 (en) | Pharmaceutical composition of teriflunomide | |
| JP2008528702A5 (https=) | ||
| JP2015166342A5 (https=) | ||
| Xu et al. | Effect of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2, 3, 4, 5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate, a novel acetylcholinesterase inhibitor, on spatial cognitive impairment induced by chronic cerebral hypoperfusion in rats | |
| JP2020502137A5 (https=) | ||
| KR102254307B1 (ko) | 보관 안정성이 향상된 에페리손 약제학적 조성물 | |
| EP2599481A1 (en) | 4-phenylbutyric acid for the treatment or prevention of various diseases | |
| JP2024504902A5 (https=) | ||
| JP2022552877A (ja) | 発達障害の予防、軽減又は治療のためのイミダゾピリミジン又はイミダゾトリアジン化合物の使用 | |
| EP3723735A2 (en) | Tolperisone and non-selective cox inhibitor combinations | |
| HK40025304A (en) | Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith | |
| HK40024686A (en) | Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith | |
| JP2005187459A (ja) | スルホキシド誘導体の塩酸塩の結晶 |